Boston Scientific Loses Heart
Boston Scientific (BSX) reported that sales for the first quarter of 2007 were $2.086 billion as compared to $1.620 billion for the first quarter of 2006. EPS came in at $.08. Analysts surveyed by…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 374Friday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
IBD Weekly Top Ranked Medical Stocks
From BioHealth Investor
Pfizer Income Drops, Guidance Raises Concerns
Pfizer (PFE) did not have a very good quarter. Net income fell from $4.1 billion in the comparable quarter a year ago to $3.4 billion in the recent quarter. The company confirmed that it…
Thursday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Pfizer Looks Like a Bond Replacement – Earnings Preview (PFE)
Pfizer (PFE) reports on Friday, and just liketearing off a band-aid, investors are hoping the earnings release tobe quick, and relatively painless. Nobody’s expecting anythingspectacular on the “good news” front, while many issues both…
Merck Does OK
Merck (MRK) announced what the market expected. On that note, they are already ahead of Yahoo!. Revenue hit $5.8 billion up 7% for the quarter. EPS without restructuring costs, hit $.84, up from $.78…
Wednesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Ahead of the Earnings: Merck Gaining Respectability Again?
We can see the sweat on their brow, but all in all Merck (MRK) is running a pretty good race these days going into Thursday’s earnings. With the recent pop from news that the…
Tuesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Targacept: Late Day Volume Surge Deserves Attention
by H.S. AyoubBioHealth Investor.com
Cervical Cancer Vaccine Wars Heating Up (GSK, MRK)
GlaxoSmithKline (GSK-NYSE/ADR) has just announced more positive data on its cervical cancer vaccine called CERVARIX(R). The company has said that it demonstrated 100% protection against "HPV" (Human Papillomavirus-type 16 & 18) for precancerous lesions…
Cell Genesys Showing New Positive Study Data
Cell Genesys, Inc. (CEGE-NASDAQ) is trading up more than 7% at $5.50 in earlybird trading on thin volume this morning on its new prostate cancer studies. Yesterday it closed down at $5.10, more than…
Monday’s Top Biotech & Medical Stocks
From BioHealth Investor
Boston Scientific Begging For Good News
It’s always an interesting phenomenon when a large company becomes ultra-sensitive to news, as Boston Scientific (BSX) seems to be doing these days. BSX shares are up nearly 8% this morning to $16.20 on…